The ALL ME® Podcast

Episode 134: Weight Loss, Wellness, and the Truth About GLP-1 – Dr. Maureen Gibbons


Listen Later

The ALL ME® Podcast Weight Loss, Wellness, and the Truth About GLP-1 – Dr. Maureen Gibbons In this episode of the ALL ME Podcast, host Brian Parker discusses GLP-1 (glucagon-like peptide 1) with Dr. Maureen Gibbons, who shares her expertise on the topic. They explore the medical implications of GLP-1, its role in diabetes and weight loss, and the various FDA-approved drugs in this class. Dr. Gibbons emphasizes the importance of understanding the natural production of GLP-1 in the body and discusses the safety and side effects of these medications. The conversation also touches on who should avoid GLP-1 drugs and the broader implications for health and wellness. In this conversation, Dr. Moe discusses the long-term safety of medications for weight loss, particularly focusing on GLP-1 receptor agonists. She shares her personal experience with weight loss and the mental health benefits of these medications. The discussion also touches on the cultural shift towards using medication for cosmetic weight loss, the dangers of the gray market for medications, and the importance of seeking professional help rather than relying on unregulated sources. Dr. Moe emphasizes the need for a supportive community and the role of coaching in achieving sustainable health outcomes. Takeaways GLP-1 is crucial for understanding modern weight loss drugs. Dr. Maureen Gibbons has extensive experience in lifestyle medicine. The half-life of GLP-1 drugs varies significantly. There are multiple FDA-approved GLP-1 medications available. GLP-1 drugs can help with both diabetes and weight loss. Natural production of GLP-1 can be enhanced through diet and exercise. Safety profiles of GLP-1 drugs are generally favorable. Every medication comes with risks that need to be considered. Certain populations should avoid GLP-1 medications. Behavioral change is essential for effective health management. Long-term safety of medications is a personal decision. Weight loss medications can provide mental health benefits. Cultural shifts towards medication for weight loss raise concerns. The gray market for medications poses significant risks. Seeking professional help is crucial for safe treatment. Behavioral changes are essential for sustainable weight loss. Coaching can help navigate the complexities of health care. Insurance coverage for medications is inconsistent and complex. The cost of medications is gradually decreasing. Community support is vital for individuals seeking help. Chapters 00:00 Introduction to GLP-1 and Its Importance 02:32 Dr. Maureen Gibbons: Background and Expertise 06:52 Understanding GLP-1: Medical Insights 10:09 The Functionality of GLP-1 Drugs 12:17 Exploring FDA Approved GLP-1 Drugs 14:24 The Role of GLP-1 in Weight Loss and Diabetes 17:23 Natural Ways to Boost GLP-1 Production 20:48 Safety and Side Effects of GLP-1 Drugs 26:30 Who Should Avoid GLP-1 Medications? 29:04 Long-Term Safety of Medications 35:58 The Role of Medication in Weight Loss 43:01 Navigating the Gray Market for Medications 50:06 Final Thoughts on Seeking Help Follow Us: Twitter: @theTHF Instagram: @theTHF Facebook: Taylor Hooton Foundation #ALLMEPEDFREE Contact Us: Email: [email protected] Phone: 214-449-1990 ALL ME Assembly Programs: http://taylorhooton.org/education-resources/face-to-face-programs/
...more
View all episodesView all episodes
Download on the App Store

The ALL ME® PodcastBy The Taylor Hooton Foundation

  • 5
  • 5
  • 5
  • 5
  • 5

5

50 ratings


More shows like The ALL ME® Podcast

View all
Prep Life by Glam Girl Bikini

Prep Life

263 Listeners

The Shawn Ryan Show by Shawn Ryan

The Shawn Ryan Show

44,761 Listeners

The Bikini and the Brain by Adam Bonilla/ Ashley Kaltwasser

The Bikini and the Brain

403 Listeners

The ProPhysique Code by Paul Revelia

The ProPhysique Code

146 Listeners

Huberman Lab by Scicomm Media

Huberman Lab

29,265 Listeners

The Girl Gainz Podcast by Alexis Adams & Amber Pacholok

The Girl Gainz Podcast

60 Listeners

Peptide of The Week by JD Denham and Will Haas

Peptide of The Week

11 Listeners